tiprankstipranks
Trending News
More News >
Stella Chemifa Corporation (JP:4109)
:4109
Advertisement

Stella Chemifa (4109) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4109

Stella Chemifa

(OTC:4109)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 4o)
Rating:70Outperform
Price Target:
¥4,488.00
▲(10.00% Upside)
Stella Chemifa's strong financial performance and stable valuation metrics are the primary drivers of its overall score. However, the technical analysis indicates a lack of strong momentum, which slightly dampens the overall outlook.

Stella Chemifa (4109) vs. iShares MSCI Japan ETF (EWJ)

Stella Chemifa Business Overview & Revenue Model

Company DescriptionStella Chemifa Corporation manufactures and sells inorganic fluorine compounds in Japan and internationally. It offers hydrofluoric acid, buffered hydrofluoric acid, and etching solutions used in semiconductors, liquid crystal products, and solar batteries; calcium, aluminum, lithium, strontium, barium, magnesium, zinc, and lead fluoride used in optical materials; and lithium hexafluorophosphate for batteries. The company also provides boron trifluoride, boron trifluoride diethyl ether, boron trifluoride dimethyl ether, boron trifluoride n-butyl ether, boron trifluoride tetrahydrofuran, boron trifluoride phenol, boron trifluoride monoethyl amine, boron trifluoride piperidine, and triethylamine 3HF used in reactive catalysts; and anhydrous hydrofluoric acid and 55% hydrofluoric acid used in surface treatment and alternatives for CFCs. In addition, it offers potassium fluoroborate and boric acid for nuclear energy applications; tin fluoride (II) USP used in GMP-compliant products; and other products, such as fluorosilicic acid, potassium fluorosilicate, ammonium fluorosilicate, fluoroboric acid, tin fluoroborate, copper fluoroborate, lead fluoroborate, zinc fluoroborate, sodium fluoroborate, potassium fluoroborate, ammonium hydrogenfluoride, sodium fluoride, potassium fluoride, ammonium fluoride, potassium hexafluorozirconate, potassium hexafluorotitanate, refined calcium fluoride, and potassium hexafluorophosphate. Further, the company transports a range of special chemical substances, high-pressure gas, hazardous materials, and related products. Additionally, it develops Boron Neutron Capture therapy for the treatment of cancer. The company was formerly known as Hashimoto Chemical Corporation and changed its name to Stella Chemifa Corporation in 1997. Stella Chemifa Corporation was founded in 1916 and is headquartered in Osaka, Japan.
How the Company Makes MoneyStella Chemifa generates revenue through the production and sale of its specialty chemical products. The company has established key revenue streams through its diverse product offerings, catering to various industries such as pharmaceuticals, electronics, and agriculture. Additionally, Stella Chemifa engages in long-term contracts with major clients, ensuring steady income. The company also benefits from strategic partnerships with research institutions and other corporations, which enhance its product development capabilities and market reach. Furthermore, the focus on sustainability and innovation allows Stella Chemifa to differentiate its products, thereby capturing higher-value markets and contributing to its overall earnings.

Stella Chemifa Financial Statement Overview

Summary
Stella Chemifa demonstrates strong financial performance with consistent revenue growth and stable margins. The balance sheet is robust with low leverage and high equity, supporting financial stability. Cash flow generation is solid, although free cash flow has shown some volatility.
Income Statement
79
Positive
Stella Chemifa has demonstrated strong financial performance with a consistent increase in revenue over the years. The gross profit margin and net profit margin have remained stable, indicating efficient cost management. The EBIT and EBITDA margins show robust operational efficiency, although there was a slight dip in net profit margin in 2025. Revenue growth has been positive, reflecting a healthy demand for products.
Balance Sheet
82
Very Positive
The company maintains a strong balance sheet with a low debt-to-equity ratio, indicating prudent financial leverage. The return on equity is healthy, showcasing effective utilization of shareholder funds. The equity ratio is high, suggesting financial stability and a strong asset base. The company's ability to cover its liabilities with equity is a positive aspect.
Cash Flow
74
Positive
Stella Chemifa shows a strong operating cash flow, which consistently exceeds net income, indicating good cash generation from operations. Free cash flow has been volatile but showed significant growth in 2025. The free cash flow to net income ratio points to efficient cash management, though capital expenditures have fluctuated.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue36.33B36.29B30.45B35.38B37.30B32.89B
Gross Profit8.62B8.26B6.45B7.41B8.90B8.21B
EBITDA7.23B7.07B5.41B5.99B9.59B7.04B
Net Income2.90B2.89B1.84B2.28B5.36B2.96B
Balance Sheet
Total Assets58.99B60.73B58.62B55.47B56.60B52.93B
Cash, Cash Equivalents and Short-Term Investments14.66B16.64B16.23B15.10B15.89B15.57B
Total Debt5.58B5.37B4.93B3.92B5.42B8.71B
Total Liabilities14.58B15.73B14.12B12.31B13.87B16.18B
Stockholders Equity44.18B44.75B44.26B42.92B42.22B36.27B
Cash Flow
Free Cash Flow0.002.95B683.00M1.05B2.68B4.92B
Operating Cash Flow0.007.12B6.54B5.63B5.40B7.35B
Investing Cash Flow0.00-4.32B-5.83B-3.28B-5.67B-2.46B
Financing Cash Flow0.00-2.83B-141.00M-3.72B94.00M-3.00B

Stella Chemifa Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4080.00
Price Trends
50DMA
4130.88
Negative
100DMA
3983.58
Positive
200DMA
3949.18
Positive
Market Momentum
MACD
-5.29
Positive
RSI
46.53
Neutral
STOCH
37.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4109, the sentiment is Negative. The current price of 4080 is below the 20-day moving average (MA) of 4142.66, below the 50-day MA of 4130.88, and above the 200-day MA of 3949.18, indicating a neutral trend. The MACD of -5.29 indicates Positive momentum. The RSI at 46.53 is Neutral, neither overbought nor oversold. The STOCH value of 37.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4109.

Stella Chemifa Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥62.15B13.492.65%8.13%5.35%
73
Outperform
€70.89B14.1510.57%2.16%15.12%40.72%
73
Outperform
¥47.94B9.454.83%0.10%
71
Outperform
¥59.37B13.753.36%5.45%25.48%
70
Outperform
$51.30B16.856.67%4.12%13.87%47.77%
65
Neutral
¥58.48B22.381.67%-2.91%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4109
Stella Chemifa
4,080.00
-347.65
-7.85%
JP:4187
Osaka Organic Chemical Industry Ltd.
3,200.00
273.31
9.34%
JP:4047
Kanto Denka Kogyo Co., Ltd.
1,018.00
66.34
6.97%
JP:4078
Sakai Chemical Industry Co., Ltd.
2,844.00
318.43
12.61%
JP:4221
Okura Industrial Co., Ltd.
5,210.00
2,646.78
103.26%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,500.00
231.22
10.19%

Stella Chemifa Corporate Events

Stella Chemifa Completes Treasury Share Disposal for Employee Incentives
Jun 30, 2025

Stella Chemifa Corporation has completed the payment procedures for the disposal of 13,850 treasury shares as restricted stock for employees, a move resolved by the Board of Directors on May 19, 2025. This strategic action, involving a total disposal value of 50,621,750 yen, aims to incentivize 213 employees, potentially enhancing employee engagement and aligning their interests with the company’s long-term goals.

Stella Chemifa Announces Treasury Share Disposal for Employee Incentives
May 19, 2025

Stella Chemifa has announced a resolution to dispose of 13,850 treasury shares as restricted stock for 213 employees, aiming to align employee interests with shareholders and enhance corporate value. This move is part of a compensation plan with performance conditions, requiring employees to meet specific targets to lift transfer restrictions on the shares, which are priced at 3,655 yen each, reflecting the market value.

Stella Chemifa Revises Director Compensation Plan to Boost Performance Alignment
May 19, 2025

Stella Chemifa Corporation announced a partial revision to its share-based compensation plan for eligible directors, aiming to enhance motivation and align director compensation with company performance and share value. The revised plan increases the maximum contribution amount and adjusts the calculation method for share allocation, reflecting the company’s commitment to improving medium- to long-term business performance and corporate value.

Stella Chemifa Reports Strong Financial Growth for FY 2025
May 13, 2025

Stella Chemifa Corporation reported a strong financial performance for the fiscal year ended March 31, 2025, with a notable increase in sales revenue and profits compared to the previous year. The company achieved a 19.2% rise in sales revenue and a substantial 56.7% increase in profit attributable to owners of the parent. This growth reflects the company’s robust operational strategies and market positioning, positively impacting stakeholders and reinforcing its industry standing.

Stella Chemifa Rejects Shareholder Proposals to Maintain Strategic Flexibility
May 9, 2025

Stella Chemifa Corporation announced that its Board of Directors has decided to reject all shareholder proposals submitted by Nippon Active Value Fund plc for the upcoming Ordinary General Meeting. The proposals included amendments to the Articles of Incorporation and the acquisition of treasury stock, among others. The Board believes that maintaining decision-making within the Board allows for more agile and flexible management, aligning with their strategy to enhance medium- to long-term corporate value and shareholder returns.

Stella Chemifa Unveils New Shareholder Return Policy
May 9, 2025

Stella Chemifa Corporation has announced a new shareholder return policy as part of its 4th Medium-Term Management Plan, aiming for a return on equity of 8% or more by March 2028. The policy emphasizes stable dividends and a total return ratio of 100% or more, balancing growth investments with shareholder returns to enhance corporate value.

Stella Chemifa Unveils Ambitious Medium-Term Growth Plan
May 9, 2025

Stella Chemifa has announced its Fourth Medium-Term Management Plan for fiscal years ending 2026 to 2028, aiming for significant growth and value creation. The plan includes strengthening sales in semiconductor markets, expanding electronic materials sales channels, and enhancing R&D efforts. The company targets increased sales revenue and operating profit by 2028, with a new shareholder return policy aiming for a total return ratio of 100% or more over the plan period.

Stella Chemifa Announces Dividend of Surplus for Fiscal Year 2025
May 9, 2025

Stella Chemifa Corporation has announced a resolution by its Board of Directors to pay dividends of surplus, with a record date of March 31, 2025. The dividend per share is set at ¥85, reflecting the company’s policy to maintain stable payments and a total return ratio of 100% for the fiscal year. This decision underscores Stella Chemifa’s dedication to shareholder returns, despite a slight decrease from the previous fiscal year’s dividend per share of ¥94.

Stella Chemifa Reports Strong Financial Growth and Increased Dividends for FY2025
May 9, 2025

Stella Chemifa reported significant growth in its financial performance for the fiscal year ended March 31, 2025, with a 19.2% increase in sales revenue and a 59.4% rise in operating profit compared to the previous year. The company also announced a higher dividend payout, reflecting its strong financial position and commitment to returning value to shareholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 18, 2025